-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • NewGenIvf Group (NASDAQ:NIVF) shares increased by 187.5% to $1.45 during Monday's regular session.
  • Check-Cap (NASDAQ:MBAI) stock rose 140.26% to $3.58. The company's market cap stands at $9.1 million.
  • Acumen Pharmaceuticals (NASDAQ:ABOS) stock rose 19.88% to $2.37. The company's market cap stands at $119.9 million.
  • Jin Medical International (NASDAQ:ZJYL) shares increased by 17.68% to $0.16. The company's market cap stands at $20.9 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock increased by 16.58% to $2.53. The company's market cap stands at $6.1 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 15.29% to $11.38. The company's market cap stands at $9.0 million.

Losers

  • NovaBay Pharmaceuticals (AMEX:NBY) shares declined by 32.2% to $3.19 during Monday's regular session. The market value of their outstanding shares is at $594.2 million.
  • INVO Fertility (NASDAQ:IVF) stock fell 17.8% to $1.34. The company's market cap stands at $24.6 million.
  • Exicure (NASDAQ:XCUR) stock declined by 17.21% to $5.1. The market value of their outstanding shares is at $39.2 million.
  • Revolution Medicines (NASDAQ:RVMD) stock fell 16.88% to $97.78. The market value of their outstanding shares is at $22.7 billion.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock decreased by 15.61% to $2.11. The market value of their outstanding shares is at $4.0 million.
  • Medicus Pharma (NASDAQ:MDCX) stock fell 14.6% to $1.17. The company's market cap stands at $33.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending